Compared to healthy individuals and idiopathic-PD patients, GBA-associated PD (GBA-PD) patients have reduced CSF GC activity, correlating with elevated levels of GC substrate glucosylceramide and reduced levels of its downstream metabolite sphingomyelin in CSF [119,120]. This evidence concerns the gene GC and Parkinson disease.